MicroRNA 4668 (miR-4668)

MicroRNA 4668 (miR-4668, also known as hsa-mir-4668) is a small non-coding RNA molecule belonging to the microRNA family, which are typically 21–23 nucleotides long and regulate gene expression post-transcriptionally[1][3][5]. Like other microRNAs, miR-4668 is produced through a multistep biogenesis pathway, including processing by the enzymes Drosha and Dicer, ultimately generating a mature miRNA that incorporates into the RNA-Induced Silencing Complex (RISC) to target specific mRNAs for degradation or translational suppression[2][3]. While the general biological functions of microRNAs include regulation of gene expression, cell differentiation, apoptosis, and chromatin remodeling[1][3][5], miR-4668 has also been identified as a potential novel biomarker for eosinophilic esophagitis[4]. It is a small regulatory RNA, not a protein or receptor, and thus is not typically considered a direct therapeutic target. There is scant evidence that miR-4668 is a direct therapeutic target (e.g., receptor, enzyme, transporter), and no specific drugs are known to interact with it directly. Consequently, there are no known drugs or targeted therapies specifically interacting with miR-4668, nor defined mechanisms of action or safety concerns unique to this microRNA. Its most notable role to date is as a potential biomarker for eosinophilic esophagitis[4].

Other names

hsa-mir-4668MIR4668mir-4668